Challenges in the use of immunotherapy in metastatic melanoma - The BMJ
The most common side effects reported in melan-oma patients treated with combination CTLA-4 and PD-1 receptor antibodies include diarrhoea, rash, fatigue and prur-itus. Immune-related side effects may occur with a lower fre-quency, but can be life-threatening if not diagnosed and treated early. These typically include immune effects on the skin, ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- welcome to cancer newsline your source for news on cancer research
- treating melanoma skin cancer
- what are immunotherapy side effects european society for medical oncology
- stage iv melanoma treatment options aim with immunotherapy
- immunotherapy for melanoma cancer support community
- challenges in the use of immunotherapy in metastatic melanoma the bmj
- immunotherapy and the side effects sunnybrook health sciences centre
- advances in immunotherapy for melanoma biomed central
- managing immunotherapy related side effects touchoncology
- immunotherapy and targeted therapy in melanoma side effects
Related searches
- learning challenges in the classroom
- language challenges in the classroom
- the use of technology in education
- mental health challenges in the workplace
- student challenges in the classroom
- economic challenges in the us
- use of technology in the classroom
- cultural challenges in the workplace
- teaching challenges in the classroom
- challenges in the nursing field
- managers challenges in the workplace
- challenges in the medical field